Wacławski Jacek, Wilczek Krzysztof, Pres Damian, Krajewski Adam, Poloński Lech, Zembala Marian, Gąsior Mariusz
Department of Cardiac and Vascular Diseases, Silesian Center for Heart Diseases, Zabrze, Poland.
3 Chair and Department of Cardiology, Medical University of Silesia in Katowice, School of Medicine with the Division of Dentistry in Zabrze, Silesian Center for Heart Diseases, Poland.
Kardiochir Torakochirurgia Pol. 2015 Mar;12(1):8-13. doi: 10.5114/kitp.2015.50561. Epub 2015 Mar 31.
Balloon aortic valvuloplasty is recommended in patients not suitable for transcatheter aortic valve implantation/aortic valve replacement (TAVI/AVR) or when such interventions are temporarily contraindicated. The number of performed balloon aortic valvuloplasty (BAV) procedures has been increasing in recent years. Valvuloplasty enables the selection of individuals with severe left ventricular dysfunction or with symptoms of uncertain origin resulting from concomitant disorders (including chronic obstructive pulmonary disease [COPD]) who can benefit from destination therapy (AVR/TAVI). Thanks to improved equipment, the number of adverse effects is now lower than it was in the first years after the advent of BAV. Valvuloplasty can be safely performed even in unstable patients, but long-term results remain poor. In view of the limited availability of TAVI in Poland, it is reasonable to qualify patients for BAV more often, as it is a relatively safe procedure improving the clinical condition of patients awaiting AVR/TAVI.
对于不适合经导管主动脉瓣植入术/主动脉瓣置换术（TAVI/AVR）或此类干预措施暂时禁忌的患者，推荐进行球囊主动脉瓣成形术。近年来，已实施的球囊主动脉瓣成形术（BAV）手术数量一直在增加。瓣膜成形术能够筛选出患有严重左心室功能不全或因合并症（包括慢性阻塞性肺疾病[COPD]）导致病因不明症状的个体，这些个体可从终末期治疗（AVR/TAVI）中获益。得益于设备的改进，现在不良反应的数量比BAV出现后的最初几年有所减少。即使在不稳定的患者中也可安全地进行瓣膜成形术，但长期效果仍然不佳。鉴于波兰TAVI的可及性有限，更频繁地使患者符合BAV的条件是合理的，因为这是一种相对安全的手术，可改善等待AVR/TAVI患者的临床状况。
